|
1
|
Siegel RL, Miller KD, Fedewa SA, Ahnen DJ,
Meester RGS, Barzi A and Jemal A: Colorectal cancer statistics,
2017. CA Cancer J Clin. 67:177–193. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Siegel R, Desantis C and Jemal A:
Colorectal cancer statistics, 2014. CA Cancer J Clin. 64:104–117.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Mcquade RM, Stojanovska V, Bornstein JC
and Nurgali K: Colorectal cancer chemotherapy: The evolution of
treatment and new approaches. Curr Med Chem. 24:1537–1557. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Izumchenko E, Singh MK, Plotnikova OV,
Tikhmyanova N, Little JL, Serebriiskii IG, Seo S, Kurokawa M,
Egleston BL, Klein-Szanto A, et al: NEDD9 promotes oncogenic
signaling in mammary tumor development. Cancer Res. 69:7198–7206.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Kim M, Gans JD, Nogueira C, Wang A, Paik
JH, Feng B, Brennan C, Hahn WC, Cordon-Cardo C, Wagner SN, et al:
Comparative oncogenomics identifies NEDD9 as a melanoma metastasis
gene. Cell. 125:1269–1281. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Sima N, Cheng X, Ye F, Ma D, Xie X and Lü
W: The overexpression of scaffolding protein NEDD9 promotes
migration and invasion in cervical cancer via tyrosine
phosphorylated FAK and SRC. PLoS One. 8:e745942013. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
O'Neill G, Seo S, Serebriiskii IG, Lessin
SR and Golemis EA: A new central scaffold for metastasis: Parsing
HEF1/Cas-L/NEDD9. Cancer Res. 67:8975–8979. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zhang S, Wu L, Liu Q, Chen K and Zhang X:
Elevated expression of NEDD9 is associated with metastatic activity
in gastric cancer. Onco Targets Ther. 8:633–640. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Kong C, Wang C, Wang L, Ma M, Niu C, Sun
X, Du J, Dong Z, Zhu S, Lu J and Huang B: NEDD9 is a positive
regulator of epithelial-mesenchymal transition and promotes
invasion in aggressive breast cancer. PLoS One. 6:e226662011.
View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Chang JX, Gao F, Zhao GQ and Zhang GJ:
Expression and clinical significance of NEDD9 in lung tissues. Med
Oncol. 29:2654–2660. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Cui X, Shen K, Xie Z, Liu T and Zhang H:
Identification of key genes in colorectal cancer using random walk
with restart. Mol Med Rep. 15:867–872. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Li P, Zhou H, Zhu X, Ma G, Liu C, Lin B
and Mao W: High expression of NEDD9 predicts adverse outcomes of
colorectal cancer patients. Int J Clin Exp Pathol. 7:2565–2570.
2014.PubMed/NCBI
|
|
13
|
Dai J, Van Wie PG, Fai LY, Kim D, Wang L,
Poyil P, Luo J and Zhang Z: Downregulation of NEDD9 by apigenin
suppresses migration, invasion, and metastasis of colorectal cancer
cells. Toxicol Appl Pharmacol. 311:106–112. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Thiery JP: Epithelial-mesenchymal
transitions in tumour progression. Nat Rev Cancer. 2:442–454. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Kalluri R and Weinberg RA: The basics of
epithelial-mesenchymal transition. J Clin Invest. 119:1420–1428.
2009. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Min J, Liu L, Li X, Jiang J, Wang J, Zhang
B, Cao D, Yu D, Tao D, Hu J, et al: Absence of DAB2IP promotes
cancer stem cell like signatures and indicates poor survival
outcome in colorectal cancer. Sci Rep. 5:165782015. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Guerrero MS, Parsons JT and Bouton AH: Cas
and NEDD9 contribute to tumor progression through dynamic
regulation of the cytoskeleton. Genes Cancer. 3:371–381. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang Z, Shen M, Lu P, Li X, Zhu S and Yue
S: NEDD9 may regulate hepatocellular carcinoma cell metastasis by
promoting epithelial-mesenchymal-transition and stemness via
repressing Smad7. Oncotarget. 8:1714–1724. 2017.PubMed/NCBI
|
|
19
|
Weston CR and Davis RJ: The JNK signal
transduction pathway. Curr Opin Genet Dev. 12:14–21. 2002.
View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Wagner EF and Nebreda AR: Signal
integration by JNK and p38 MAPK pathways in cancer development. Nat
Rev Cancer. 9:537–549. 2009. View
Article : Google Scholar : PubMed/NCBI
|
|
21
|
Bode AM and Dong Z: The functional
contrariety of JNK. Mol Carcinog. 46:591–598. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zhao X, Wu X, Qian M, Song Y, Wu D and
Zhang W: Knockdown of TGF-β1 expression in human umbilical cord
mesenchymal stem cells reverts their exosome-mediated EMT promoting
effect on lung cancer cells. Cancer Lett. 428:34–44. 2018.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Wang Y, Xu Y, Yan W, Han P, Liu J, Gong J,
Li D, Ding X, Wang H, Lin Z, et al: CFIm25 inhibits hepatocellular
carcinoma metastasis by suppressing the p38 and JNK/c-Jun signaling
pathways. Oncotarget. 9:11783–11793. 2018.PubMed/NCBI
|
|
24
|
Dong Y, Wu Z, He M, Chen Y, Chen Y, Shen
X, Zhao X, Zhang L, Yuan B and Zeng Z: ADAM9 mediates the
interleukin-6-induced Epithelial-Mesenchymal transition and
metastasis through ROS production in hepatoma cells. Cancer Lett.
421:1–14. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Edge SB and Compton CC: The American Joint
Committee on Cancer: The 7th edition of the AJCC cancer staging
manual and the future of TNM. Ann Surg Oncol. 17:1471–1474. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Scanlon CS, Van Tubergen EA, Inglehart RC
and D'Silva NJ: Biomarkers of epithelial-mesenchymal transition in
squamous cell carcinoma. J Dent Res. 92:114–121. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Morimoto K, Tanaka T, Nitta Y, Ohnishi K,
Kawashima H and Nakatani T: NEDD9 crucially regulates
TGF-β-triggered epithelial-mesenchymal transition and cell invasion
in prostate cancer cells: Involvement in cancer progressiveness.
Prostate. 74:901–910. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Miao Y, Li AL, Wang L, Fan CF, Zhang XP,
Xu HT, Yang LH, Liu Y and Wang EH: Overexpression of NEDD9 is
associated with altered expression of E-cadherin, β-catenin and
N-cadherin and predictive of poor prognosis in non-small cell lung
cancer. Pathol Oncol Res. 19:281–286. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Feng J, Zhao J, Xie H, Yin Y, Luo G, Zhang
J, Feng Y and Li Z: Involvement of NEDD9 in the invasion and
migration of gastric cancer. Tumour Biol. 36:3621–3628. 2015.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Khan GJ, Gao Y, Gu M, Wang L, Khan S,
Naeem F, Semukunzi H, Roy D, Yuan S and Sun L: TGF-β1 Causes EMT by
regulating N-Acetyl glucosaminyl transferases via downregulation of
non muscle myosin II-A through JNK/P38/PI3K pathway in lung cancer.
Curr Cancer Drug Targets. 18:209–219. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Choi Y, Ko YS, Park J, Choi Y, Kim Y, Pyo
JS, Jang BG, Hwang DH, Kim WH and Lee BL: HER2-induced metastasis
is mediated by AKT/JNK/EMT signaling pathway in gastric cancer.
World J Gastroenterol. 22:9141–9153. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
An J, Guo Y, Wang T, Pantuck AJ and Rettig
MB: Pomegranate extract inhibits EMT in clear cell renal cell
carcinoma in a NF-κB and JNK dependent manner. Asian J Urol.
2:38–45. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Grauzam S, Brock AM, Holmes CO, Tiedeken
JA, Boniface SG, Pierson BN, Patterson DG, Coaxum SD, Neskey DM and
Rosenzweig SA: NEDD9 stimulated MMP9 secretion is required for
invadopodia formation in oral squamous cell carcinoma. Oncotarget.
9:25503–25516. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Feng Y, Wang Y, Wang Z, Fang Z, Li F, Gao
Y, Liu H, Xiao T, Li F, Zhou Y, et al: The CRTC1-NEDD9 signaling
axis mediates lung cancer progression caused by LKB1 loss. Cancer
Res. 72:6502–6511. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Chu Q, Zhang J and Sun F: Study on
mechanism of mi R-203 inhibiting migration and invasion of breast
cancer cell MDA-MB-231 by regulating NEDD9 protein. J Diagnostics
Concepts Pract. 2014.
|
|
37
|
Shagisultanova E, Gaponova AV, Gabbasov R,
Nicolas E and Golemis EA: Preclinical and clinical studies of the
NEDD9 scaffold protein in cancer and other diseases. Gene.
567:1–11. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Guerrero MS, Parsons JT and Bouton AH: Cas
and NEDD9 contribute to tumor progression through dynamic
regulation of the cytoskeleton. Genes Cancer. 3:371–381. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Sulzmaier FJ, Jean C and Schlaepfer DD:
FAK in cancer: Mechanistic findings and clinical applications. Nat
Rev Cancer. 14:598–610. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Tikhmyanova N, Little JL and Golemis EA:
CAS proteins in normal and pathological cell growth control. Cell
Mol Life Sci. 67:1025–1048. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Ding X, Sun W and Chen J: IL-2 augments
the sorafenib-induced apoptosis in liver cancer by promoting
mitochondrial fission and activating the JNK/TAZ pathway. Cancer
Cell Int. 18:1762018. View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Li Z, Lim SK, Liang X and Lim YP: The
transcriptional coactivator WBP2 primes triple-negative breast
cancer cells for responses to Wnt signaling via the JNK/Jun kinase
pathway. J Biol Chem. 293:20014–20028. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Chen X, Liu C, Zhao R, Zhao P, Wu J, Zhou
N and Ying M: Synergetic and antagonistic molecular effects
mediated by the feedback loop of p53 and JNK between Saikosaponin D
and SP600125 on lung cancer A549 cells. Mol Pharm. 15:4974–4984.
2018. View Article : Google Scholar : PubMed/NCBI
|
|
44
|
Kubala MH, Punj V, Placencio-Hickok VR,
Fang H, Fernandez GE, Sposto R and DeClerck YA: Plasminogen
activator Inhibitor-1 promotes the recruitment and polarization of
macrophages in cancer. Cell Rep. 25:2177–2191.e7. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Hu Z, Tie Y, Lv G, Zhu J, Fu H and Zheng
X: Transcriptional activation of miR-320a by ATF2, ELK1 and YY1
induces cancer cell apoptosis under ionizing radiation conditions.
Int J Oncol. 53:1691–1702. 2018.PubMed/NCBI
|
